CSI Market
Sign In | Register

Carlsmed Inc (CARL) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CARL quarterly Cash Flow →
The data below summarizes Carlsmed Inc's cash flow activity from to Dec 31 2025, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months
Operating Activities
Income-29.63
Depreciation & amortization0.28
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-0.85
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.93
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.33
Noncash Interest0.21
Noncash Lease Expense0.54
Allowance For Doubtful Accounts Receivable Write Offs0.41
Increase Decrease In Operating Lease Liability-0.29
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-5.01
Increase (Decrease) in Accounts Payable2.32
Increase (Decrease) in Accrued Liabilities0.63
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-2.34
Other Working Capital2.49
Other Noncash Income (Expense)0.02
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-28.98
Investing Activities
Capital Expenditures-1.36
Sale of Capital Items0.00
Payments to Acquire Short-term Investments-24.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payment Of Initial Direct Costs Related To Operating Leases-0.13
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-25.48
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock93.67
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock11.92
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.64
Right Of Use Asset Obtained In Exchange For Operating Lease Liability0.59
Vesting Of Early Exercised Common Stock Options0.04
Preferred Stock Warrants Issued In Connection With Term Loan Modifications-
Unpaid Deferred Offering And Issuance Costs-
Payments For Deferred Initial Public Offering Costs-5.41
Payment Of Issuance Costs Related To Term Loan Modification-0.05
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities100.13
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-30.33
Total Cash Flow45.67
4 historic quarters locked

Sign in to unlock the full Carlsmed Inc cash flow history.

Sign In Create Free Account

About Carlsmed Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 25, 2026
  • Source: carl-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-071551

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License